Dewpoint Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-137/13/26 | Amended | $77,164,102 | $18,039,804 | Equity Only | 06b | SEC linkSEC |
| 2025-09-239/23/25 | New | $59,124,298 | $59,124,298 | Equity Only | 06b | SEC linkSEC |
| 2022-02-042/4/22 | New | $149,999,989 | $149,999,989 | Equity Only | 06b | SEC linkSEC |
| 2020-11-0211/2/20 | New | $77,097,477 | $77,097,477 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Srinivas Akkaraju, M.D. | Director |
| Srinivas Akkaraju, M.D., Ph.D. | Director |
| Regina Barzilay, Ph.D. | Director |
| Bruce Beutel | Executive |
| Olivier Brandicourt, M.D. | Director |
| Oliver Brandicourt, M.D. | Director |
| Guiseppe A. Ciaramella, Ph,D. | Director |
| Giuseppe A. Ciaramella, Ph.D. | Director |
| Giuseeppe Ciaramella, Ph.D. | Director |
| Jurgen Eckhardt, M.D. | Director |
| Juergen Eckhardt, M.D. | Director |
| Lori Escobedo | Executive |
| Anthony A. Hyman, Ph.D. | Director |
| Isaac A. Klein, M.D., Ph.D. | Executive |
| Elisabeth Leiderman | Executive |
| Mark Murcko, Ph.D. | Director |
| Amir H. Nashat | Director |
| Amir H. Nashat, Ph.D. | Director |
| Amir H. Nashat, Sc.D. | Director |
| Ameet Nathwani, M.D. | Director, Executive |
| Steven Neier, Ph.D. | Director |
| Fabio Pucci, Ph.D. | Director |
| Joel D. Sendek | Executive |
| Richard A. Young, Ph.D. | Director |
Industry: Biotechnology (See others in industry)
Address:
451 D Street, Suite 104
Boston, MA, 02210
Phone: 617-914-8448
Boston, MA, 02210
Phone: 617-914-8448